ASENAPINE

SynDRA canonical compound SYN0037959 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	DRD1 \| DRD2 \| HRH1 \| HTR1A \| HTR1B \| HTR1D \| HTR1E \| HTR2A
Mechanism of action	dopamine receptor antagonist \| serotonin receptor antagonist
Indication	bipolar disorder \| schizophrenia
Disease area	neurology/psychiatry

All known targets

Org 5222
saphris
asenapine maleate
sycrest
Asenapina
Secuado
Sycrest
Asenapi
Asenapine [INN:BAN]
Saphris (TN)
[13C,2H3]-Asenipine
Trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole
1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-met
5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3-6,7)oxepino(4,5-c)pyrrole
CHEBI:71255
RefChem:302428
cis-Asenapine
Asenapine-d3
SCHEMBL2221502
SCHEMBL29365680
SCHEMBL30413463
SCHEMBL30544842
BDBM84994
VSWBSWWIRNCQIJ-UHFFFAOYSA-N
FXB84372
QCA62178
CAS_163091
EBC-615130
NSC_163091
SB17468
LS-14560
L000898
5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
5-chloro-2-metylo-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oksepino[4,5-c]pirol
(RS,RS)-asenapina
Asenapine (as maleate)
SCHEMBL29374126
SCHEMBL6029138